University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Lisa Kroon, Pharm.D.

Pharmacist and tobacco treatment specialist

Lisa Kroon is a pharmacist and co-director of the Fontanta Tobacco Treatment Center at UCSF Medical Center. She also cares for patients in the medical center's adult Diabetes Clinic, Diabetes Teaching Center and adult Primary Care Clinic where she helps treat diabetes, chronic illnesses and tobacco dependence.

In the UCSF School of Pharmacy, Kroon is a professor and chair of the Department of Clinical Pharmacy and a . She teaches smoking cessation to pharmacy, medical and dental students at UCSF, preparing them to take an active role in tobacco treatment. Her primary research activities have been in the area of diabetes and smoking cessation.

Clinics

Diabetes Clinic at Parnassus
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2350
Fax: (415) 353–2337

Hours: Monday to Friday, 8:30 a.m. – 5 pm.

Diabetes Teaching Center
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2266
Fax: (415) 353–2337

Hours: Monday to Friday, Variable Hours

Fontana Tobacco Treatment Center
2330 Post St., Suite 420
San Francisco, CA 94115
Phone: (415) 885-7895

More about Lisa Kroon

Education

University of Michigan School of Pharmacy 1994

Residencies

UCSF Medical Center 1996

Selected Research and Publications

  1. Kroon LA, Corelli RL, Roth AP, Hudmon KS. Public perceptions of the ban on tobacco sales in San Francisco pharmacies. Tob Control. 2013 Nov; 22(6):369-71.
  2. Nam S, Janson SL, Stotts NA, Chesla C, Kroon L. Effect of culturally tailored diabetes education in ethnic minorities with type 2 diabetes: a meta-analysis. J Cardiovasc Nurs. 2012 Nov-Dec; 27(6):505-18.
  3. Wamsley M, Staves J, Kroon L, Topp K, Hossaini M, Newlin B, Lindsay C, O'Brien B. The impact of an interprofessional standardized patient exercise on attitudes toward working in interprofessional teams. J Interprof Care. 2012 Jan; 26(1):28-35.
  4. Kroon L. An analysis of dosage volume for halfway doses in the Victoza Pen. J Diabetes Sci Technol. 2011 Nov; 5(6):1625-6.
  5. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011 Jul; 93(1):1-9.
  6. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010 Aug; 33(8):1747-9.
  7. Potter MB, Gildengorin G, Wang Y, Wu M, Kroon L. Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign. J Am Pharm Assoc (2003). 2010 Mar-Apr 1; 50(2):181-7.
  8. Janson SL, Cooke M, McGrath KW, Kroon LA, Robinson S, Baron RB. Improving chronic care of type 2 diabetes using teams of interprofessional learners. Acad Med. 2009 Nov; 84(11):1540-8.
  9. Kroon L. An analysis of patient acceptance and safety of a prefilled insulin injection device. J Diabetes Sci Technol. 2009 Nov; 3(6):1439-41.
  10. Kroon L. Overview of insulin delivery pen devices. J Am Pharm Assoc (2003). 2009 Sep-Oct; 49(5):e118-31.
  11. Corelli RL, Fenlon CM, Kroon LA, Prokhorov AV, Hudmon KS. Evaluation of a train-the-trainer program for tobacco cessation. Am J Pharm Educ. 2007 Dec 15; 71(6):109.
  12. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007 Sep 15; 64(18):1917-21.
  13. Kroon LA. Drug interactions and smoking: raising awareness for acute and critical care providers. Crit Care Nurs Clin North Am. 2006 Mar; 18(1):53-62, xii.
  14. Irons BK, Kroon LA. Lipid management with statins in type 2 diabetes mellitus. Ann Pharmacother. 2005 Oct; 39(10):1714-9.
  15. Corelli RL, Kroon LA, Chung EP, Sakamoto LM, Gundersen B, Fenlon CM, Hudmon KS. Statewide evaluation of a tobacco cessation curriculum for pharmacy students. Prev Med. 2005 Jun; 40(6):888-95.
  16. Hudmon KS, Bardel K, Kroon LA, Fenlon CM, Corelli RL. Tobacco education in U.S. schools of pharmacy. Nicotine Tob Res. 2005 Apr; 7(2):225-32.
  17. Hudmon KS, Kroon LA, Corelli RL, Saunders KC, Spitz MR, Bates TR, Liang D. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81.
  18. Hudmon KS, Hemberger KK, Corelli RL, Kroon LA, Prokhorov AV. The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy. J Am Pharm Assoc (2003). 2003 Sep-Oct; 43(5):573-82.
  19. Hudmon KS, Corelli RL, Chung E, Gundersen B, Kroon LA, Sakamoto LM, Hemberger KK, Fenlon C, Prokhorov AV. Development and implementation of a tobacco cessation training program for students in the health professions. J Cancer Educ. 2003; 18(3):142-9.
  20. Assemi M, Torres NM, Tsourounis C, Kroon LA, McCart GM. Assessment of an online consumer "Ask Your Pharmacist" service. Ann Pharmacother. 2002 May; 36(5):787-92.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.